Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
95.502,33
-3,83%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vincerx Inc (VINC) Vincerx Inc (VINC) Notizie

Vincerx Inc

VINC
0,187
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:06:01
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/12/202422:02EDGAR2Form DEF 14A - Other definitive proxy statements
06/12/202422:04EDGAR2Form 8-K - Current report
04/12/202412:45GLOBEVincerx Pharma to Implement Cost-Controls to Support..
25/11/202423:05EDGAR2Form 8-K - Current report
12/11/202415:04EDGAR2Form 8-K - Current report
12/11/202415:00GLOBEVincerx Pharma Reports Third Quarter 2024 Financial Results
05/11/202415:15EDGAR2Form PRE 14A - Other preliminary proxy statements
07/10/202422:05GLOBEVincerx Reports Positive Initial Clinical Data from Ongoing..
30/9/202412:57EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
10/9/202422:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
19/8/202422:01EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
16/8/202422:01EDGAR2Form 8-K - Current report
15/8/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:06EDGAR2Form SC TO-I - Tender offer statement by Issuer
08/8/202422:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:37EDGAR2Form 8-K - Current report
08/8/202422:30GLOBEVincerx Pharma Reports Second Quarter 2024 Financial Results
02/8/202422:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/7/202422:45EDGAR2Form DEF 14A - Other definitive proxy statements
30/5/202403:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:06EDGAR2Form 8-K - Current report
14/5/202422:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:21EDGAR2Form 8-K - Current report
14/5/202422:15GLOBEVincerx Pharma Reports First Quarter 2024 Financial Results..
26/4/202406:27GLOBEVincerx Pharma Announces Pricing of Underwritten Public..
25/4/202422:01GLOBEVincerx Pharma Announces Proposed Underwritten Public..
08/4/202422:30GLOBEVincerx Pharma Presents Positive Preliminary Phase 1 Data..
01/4/202414:00GLOBEVincerx to Host Virtual Investor Event Reviewing Preliminary..
29/3/202420:20GLOBEVincerx Pharma Reports Fourth Quarter and Full Year 2023..
09/3/202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:31GLOBEVincerx to Present Three Posters at the American Association..
16/1/202412:05EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 0,187

La tua Cronologia

NASDAQ
VINC
Vincerx
LSE
69HS
Natwest.m 24
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network